SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014076
Filing Date
2024-04-09
Accepted
2024-04-09 16:30:25
Documents
16
Period of Report
2024-04-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51171
2 ex10-1.htm EX-10.1 23268
3 ex10-2.htm EX-10.2 35031
4 ex10-3.htm EX-10.3 20835
  Complete submission text file 0001493152-24-014076.txt   322853

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ghsi-20240403.xsd EX-101.SCH 3033
6 XBRL LABEL FILE ghsi-20240403_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ghsi-20240403_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3740
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 24833095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)